HD-OPM Archive
Topics › Beyond the heart

Cancer

178 posts (57 primarily about this topic) · 50 reposts and set-aside posts not shown

Start here — the best posts in this topic

  1. Replacing butter with plant oils linked to 17% lower mortality in 221,054 US adults ↩ 6 · Mar 06, 2025
  2. IV vitamin C doubled survival from 8 to 16 months in 34 pancreatic cancer patients ↩ 1 · Jan 29, 2026
  3. Swapping 1 tbsp butter daily for plant oil linked to 17% lower cancer and all-cause death Aug 04, 2025
  4. Aged garlic extract slowed plaque growth in a small CTA trial and cut colorectal adenomas Feb 27, 2026
  5. Peter Attia's 10 jerky sticks daily means over 5x average processed meat intake ↩ 1 · Oct 31, 2025
  6. Replacing 10 g/day of butter with plant oils linked to 17% lower mortality Oct 15, 2025
  7. Each daily yogurt serving linked to 14% lower CVD mortality in a 17-cohort meta-analysis Feb 16, 2025
  8. High insulin/IGF-1 tied to cancer, diabetes; Laron syndrome and low-IGF-1 mice live longer May 13, 2025
#cancer 135#coloncancer 31#statins 19#harvard 15#processedmeat 15#breastcancer 15#aging 14#mortality 14#longevity 13#pancreaticcancer 13#statinscancer 12#prostatecancer 11#seedoils 9#igf1 9#glp1 9#vitamind 9#hns 8#oliveoil 8#livercancer 8#hpfs 7#diabetes 7#mtor 7#nitrosamines 7#aspirin 7#butter 6#canolaoil 6#evoo 6#unsaturatedfat 6#vegetableoils 6#protein 6#daraxonrasib 6#ras 6#coffee 6#liver 6#soybeanoil 5#vitaminc 5#cvd 5#dogs 5#dairy 5#microbiome 5

Replacing butter with plant oils linked to 17% lower mortality in 221,054 US adults

Mar 06, 2025 · Louis Nervegna ♥ 17 · 💬 68 ↩ 6 Fats & oils (saturated fat, seed oils, omega-6, olive oil)

Louis summarizes a Harvard/Brigham cohort analysis of the Nurses' Health Study, HPFS and NHS II covering over 30 years. Higher butter intake was associated with higher all-cause and cancer mortality, while plant oils (especially olive, canola and soybean) were associated with lower all-cause, cancer and cardiovascular mortality.

Replacing 10 g/day of butter with plant oils linked to 17% lower mortality

Oct 15, 2025 · Louis Nervegna ♥ 19 · 💬 13 Fats & oils (saturated fat, seed oils, omega-6, olive oil)

Louis shares Harvard research on 221,054 people from the Nurses' Health Studies I and II and the Health Professionals Follow-Up Study, published in JAMA Internal Medicine. Higher plant-oil intake (especially soybean, canola, olive) was linked to lower total, cancer and cardiovascular mortality, while butter was linked to higher total and cancer mortality; a modeled swap of 10 g butter for plant oils lowered mortality by 17%.

Each daily yogurt serving linked to 14% lower CVD mortality in a 17-cohort meta-analysis

Feb 16, 2025 · Gokhan Can ♥ 19 · 💬 12 Meat, eggs & dairy

A systematic review and dose-response meta-analysis of 17 cohort studies (896,871 participants) found higher yogurt intake was associated with lower all-cause and cardiovascular mortality, with the largest benefit around 0.5 servings per day and no clear further gain above that. No significant association was seen with cancer mortality. As an observational analysis, it shows association, not causation.

High insulin/IGF-1 tied to cancer, diabetes; Laron syndrome and low-IGF-1 mice live longer

May 13, 2025 · Louis Nervegna ♥ 23 · 💬 13 Aging & longevity

Louis praises a video on height, insulin/IGF-1 and longevity and lays out his argument: diet (refined starch/sugar and excess animal protein) is the main driver of IGF-1, and low IGF-1 is linked to lower cancer and diabetes risk. He cites Laron syndrome, with no documented cancer deaths, little diabetes and less heart disease and Alzheimer's, and a long-lived low-IGF-1 mouse. Claims come from the post and videos, not named papers.

'Uncured' and 'nitrate-free' processed meats can carry as many or more nitrosamines

Jul 10, 2024 · Louis Nervegna ♥ 13 · 💬 16 ↩ 19 Meat, eggs & dairy

The poster warns that jerky, bacon, sausage and deli meats labeled natural or uncured use celery juice or powder as nitrate sources, avoiding USDA nitrite limits while still forming carcinogenic nitrosamines when cured and heated. Cured meat is a WHO group 1 carcinogen and shows the worst hazard ratios of any food besides trans fats in cohorts.

Swapping 1 tbsp butter for plant oil linked to 17% lower cancer and all-cause death

Sep 14, 2026 · Louis Nervegna ♥ 17 · 💬 12 Fats & oils (saturated fat, seed oils, omega-6, olive oil)

Louis shares an AHA press release on Harvard cohort data (Nurses' Health Study I and II, Health Professionals) for 221,054 adults. Replacing a daily tablespoon of butter with unsaturated plant oil was associated with lower cancer and total mortality, and each extra tablespoon of butter with higher cancer risk. Olive, canola and soybean oil showed the biggest benefits.

Meta-analysis of 4.3 million: moderate wine not linked to higher overall cancer risk

Jan 05, 2025 · Louis Nervegna ♥ 15 · 💬 17 ↩ 3 Alcohol, smoking & vaping

Louis shares Dr. Brian Lawenda's post on a Frontiers in Nutrition meta-analysis of 73 studies, covering over 4.3 million participants, that found moderate wine consumption (up to one drink/day for women, two for men) was not associated with increased overall cancer risk and might lower some cancer types. The post questions treating wine like beer and spirits.

Statin RCT meta-analyses show no increase or decrease in cancer risk

Dec 31, 2024 · Louis Nervegna ♥ 11 · 💬 13 Statins

Louis compiles meta-analyses of randomized trials showing statins neither raise nor lower cancer incidence or mortality, plus cohort studies suggesting neutral or lower cancer risk, e.g. prostate cancer. He adds that RCTs and prospective cohorts sit at the top of the evidence hierarchy.

IV vitamin C plus chemotherapy doubled survival to 16 months in pancreatic cancer trial

Dec 04, 2024 · Louis Nervegna ♥ 22 · 💬 17 ↩ 1

Louis shares a small randomized phase 2 trial at the University of Iowa in metastatic pancreatic cancer: high-dose intravenous vitamin C added to chemotherapy doubled median overall survival and was stopped early for benefit. He notes it is unrelated to heart disease and that IV vitamin C has a long controversial history.

Heart disease and cancer share aging as a cause; ideal CV health cut cancer 51% in ARIC

Dec 31, 2024 · Louis Nervegna ♥ 7 · 💬 22 ↩ 1

Louis rejects the claim that risk of CVD plus risk of cancer equals zero. Both share age as their main risk factor, so optimizing heart risk factors also lowers cancer risk. In the ARIC cohort (13,253 people, 17-19 years), 6-7 ideal AHA metrics were linked to 51% lower cancer risk than 0 ideal metrics.

Low LDL in cancer patients reflects reverse causality: tumours scavenge LDL

May 25, 2026 · Louis Nervegna ♥ 17 · 💬 12 LDL, ApoB & lipid panel

Louis explains that rapidly dividing tumour cells take up circulating LDL, so LDL falls in people with cancer and observational data show low LDL with higher cancer mortality. The shared 2026 Science Advances study found aggressive breast cancers with TP53 mutations depend on cholesterol, and blocking PI5P4K enzymes trapped cholesterol and disrupted mTOR signalling.

Small MSK trial: high-fiber plant-based diet delayed progression of precursor myeloma

Dec 23, 2024 · Louis Nervegna ♥ 17 · 💬 12

A first-of-its-kind Memorial Sloan Kettering trial gave 20 overweight people with precursor blood disorders 12 weeks of plant-based meals with coaching. None had progressed at one year, and two with previously progressing disease improved. Researchers think increased gut butyrate may be involved; a 150-person trial (NUTRIVENTION-3) is enrolling.

Moli-sani: more than 3 tablespoons of olive oil daily linked to 28% lower cancer mortality

Mar 20, 2025 · Louis Nervegna ♥ 15 · 💬 9 Fats & oils (saturated fat, seed oils, omega-6, olive oil)

Louis shares a summary of a 2024 Moli-sani Study analysis of 22,895 Italian adults followed for 12 years. Consuming over 3 tablespoons of olive oil daily was associated with 28% lower cancer mortality versus under 1.5 tablespoons, partly mediated by lower blood pressure and resting heart rate. The summary stresses the observational design and self-reported diet.

NEJM 2020 dairy review: a mixed bag, best for fermented forms, weak for fractures

Jan 23, 2025 · Louis Nervegna ♥ 6 · 💬 21 Meat, eggs & dairy

Louis highlights the widely cited 2020 NEJM review on dairy and disease risk. It concludes that high dairy intake is not supported for preventing fractures, is not clearly linked to weight, diabetes or CVD, and may raise prostate and endometrial cancer risk while lowering colorectal cancer risk. Effects depend on the comparison food: dairy fares better than processed red meat or sugary drinks but worse than nuts.

High vitamin B12 in a multivitamin did not raise disease risk in a 14-year Harvard trial

Oct 02, 2026 · Louis Nervegna ♥ 14 · 💬 9 Supplements & vitamins

The poster argues it is unlikely high B12 intake causes cancer or clonal disease. The Physicians' Health Study multivitamin trial, which contained 10 times the RDA of B12, found no increase in major disease over 14 years and an 8% lower overall cancer risk. Nurses' and Physicians' cohorts also found no B12-disease link, except combined B12 and B6 with hip fracture, which vanished for B12 alone.

Conventional produce beats no produce: natural plant carcinogens dwarf pesticide residues

May 09, 2026 · Louis Nervegna ♥ 17 · 💬 10 Nuts, fish, coffee, tea, cocoa & other foods

Louis argues that, while organic is fine if affordable, eating conventionally grown fruit and vegetables is much better than skipping them. He cites Ames's PNAS papers showing 99.99% by weight of dietary pesticides are plants' own natural defense chemicals, and that natural carcinogens in produce far exceed synthetic residues.

EVITA trial: vitamin C lowered deaths in clonal blood conditions (exploratory result)

Sep 29, 2026 · Louis Nervegna ♥ 15 · 💬 8 Supplements & vitamins

In the small phase 2 EVITA randomized trial of oral vitamin C in clonal cytopenia and lower-risk myeloid cancers, the vitamin C group had 65% lower risk of death (11 vs 24 deaths) and fewer serious adverse events. Survival was exploratory and the primary endpoint of clonal growth showed no difference. The poster speculates relevance to CHIP and cardiovascular disease but calls it a big unproven leap.

Whey protein is highly insulinogenic; Willett wary of powders and IGF-1 cancer risk

Dec 13, 2024 · Louis Nervegna ♥ 15 · 💬 10 ↩ 2 Protein

Louis argues processed whey spikes insulin more than glucose or white bread and may raise insulin/IGF-1, which promote cancer cell growth. He cites Walter Willett's 2017 book cautioning that protein supplements add little muscle without exercise and that BCAAs increase IGF-1, which may raise breast and prostate cancer risk.

Personalized mRNA vaccine succeeds in phase 3 melanoma trial after ~50% phase 2 benefit

Aug 20, 2026 · Louis Nervegna ♥ 12 · 💬 12

A personalized mRNA vaccine plus Keytruda improved recurrence-free and distant metastasis-free survival in a phase 3 trial of more than 1,100 patients with melanoma. The earlier phase 2 trial showed roughly a 50% reduction in recurrence or death at 5 years. Approval might come as early as 2027, and trials are under way in other cancers.

Seed oils don't raise inflammation markers; butter linked to higher mortality

Mar 10, 2025 · Louis Nervegna ♥ 7 · 💬 11 Fats & oils (saturated fat, seed oils, omega-6, olive oil)

Louis quotes a news article in which Martha Belury says omega-6 linoleic acid does not significantly change blood inflammatory markers and that the omega-6 to omega-3 imbalance claim is oversimplified. It also reports the Brigham and Women's study of over 200,000 adults for 30+ years: highest butter intake linked to 15% higher mortality, highest plant oil intake to 16% lower.

Cancer is a disease of aging; young-onset colorectal rise is small in absolute terms

Dec 30, 2024 · Louis Nervegna ♥ 9 · 💬 11 ↩ 1

Louis agrees with Dr. Andrea Love that cancer is many diseases whose main common factor is age, so prevention is best served by slowing aging via diet, exercise and lifestyle. The shared post says the chance of being diagnosed with colorectal cancer under 50 is 0.3%, and the recent increase is small in absolute terms, though still worth lowering.

Ketogenic diet associated with 67% vs 8% three-year survival in a tiny glioblastoma study

Mar 02, 2025 · Louis Nervegna ♥ 9 · 💬 10

Louis shares an 18-patient observational study in glioblastoma in which patients following a ketogenic diet alongside standard treatment had much higher 3-year survival. He cautions that the study is tiny and evidence for keto in this tumor has been mixed; the shared post lists nutrient sufficiency and calorie control as key considerations.

COVID mRNA vaccination before surgery tied to doubled glioblastoma survival (preprint)

Aug 17, 2026 · Louis Nervegna ♥ 25 · 💬 3

A preprint from UAB found that 187 glioblastoma patients vaccinated against COVID within 100 days before biopsy or surgery had median survival of 743 days vs 349 days unvaccinated. The association was not seen with flu, pneumonia or shingles vaccines. Louis cautions about healthy-user bias but notes all patients were treated at one hospital, and says a randomized trial is needed.

Aspirin blocks platelet TXA2 suppression of T cells and reduces metastasis in mice

Dec 07, 2025 · Louis Nervegna ♥ 18 · 💬 4 Aspirin, antiplatelets & blood thinners

Louis shares a 2025 Nature study showing that platelet-derived thromboxane A2 binds CD8+ T cells and, via ARHGEF1, weakens their anti-tumor activity. Aspirin or COX-1 inhibitors lifted this and reduced metastatic burden in mouse melanoma and lung models, only in animals with intact T-cell immunity, suggesting a mechanism for aspirin's apparent cancer protection.

Statin plus sildenafil may block cancer metastasis in preclinical models

Jul 27, 2026 · Louis Nervegna ♥ 16 · 💬 4

A 2026 Cancer Research study found sildenafil (a PDE5 inhibitor) caused cholesterol to accumulate in lysosomes of mouse and human cancer models, limiting cholesterol available to cancer cells and impairing their migration and spread. Combining it with a statin, which blocks cholesterol production, gave stronger anti-metastatic effects than either alone. Louis notes the research is preclinical but promising.

Young-adult colon cancer 'doubling' means 0.0032% to 0.0064% a year, not soaring cancer

Apr 23, 2025 · Louis Nervegna ♥ 6 · 💬 17

Louis puts the 'colon cancer doubled in young people' claim in context: in 2024, 6.4 per 100,000 people aged 20-39 were diagnosed, versus about half that before. He argues this tiny change barely affects total cancer rates and that overall cancer death rates have fallen sharply over 40 years. Off the cardiovascular focus.

Isoleucine and valine fuel prostate cancer by boosting tumor cholesterol

Aug 26, 2026 · Louis Nervegna ♥ 7 · 💬 9

Louis notes that isoleucine, valine and methionine shorten mouse lifespan, and a 2026 Nature Metabolism study links isoleucine and valine to prostate cancer progression. Their breakdown produces propionyl-CoA, which enhances the cancer cells' cholesterol synthesis, transport and storage, supplying lipids for growth.

Stanford experts say colonoscopy still matters despite a trial raising doubts

Oct 16, 2026 · Louis Nervegna ♥ 4 · 💬 20

A Stanford Medicine news piece responds to a recent trial that suggested colonoscopy may not reduce colon cancer deaths. Experts call the findings questionable and argue that screening should not be skipped. The post adds no detail beyond the shared headline.

Six lines of evidence favor whole-food plant protein over red and processed meat

Nov 12, 2026 · Louis Nervegna ♥ 12 · 💬 3 ↩ 1 Protein

Louis recommends an article by group member Mert Erogul MD on protein and aging. It argues six lines of evidence converge: growth-signaling genetics, IGF-1 biomarker data, rodent protein restriction through FGF21 and mTORC1, the roles of methionine, isoleucine and valine, short-term human trials, and epidemiology showing source matters more than amount. Plant protein from whole foods is favored.

Statins neither cause nor cure cancer: meta-analyses of randomized trials show no effect

Dec 31, 2024 · Gokhan Can ♥ 9 · 💬 4 Statins

Reviews the evidence on statins and cancer. A 2012 meta-analysis of 134,537 participants in 22 RCTs found identical cancer incidence (1.4% per year) and mortality (0.5% per year) in statin users and non-users, and a 2023 meta-analysis of 35 RCTs found the same. Anticancer effects in specific contexts remain preclinical or suggestive.

Personalized mRNA melanoma vaccine could extend to other cancers, with trials ongoing

Aug 20, 2026 · Louis Nervegna ♥ 15 · 💬 4 ↩ 1

Louis adds that the real promise of the personalized mRNA vaccine is its use across cancers beyond melanoma. The shared physician explanation stresses it treats cancer after tumor removal rather than preventing it. Trials are ongoing in non-small cell lung, kidney and bladder cancer.

Ultraprocessed food linked to 45% higher early-onset colorectal adenoma odds

Dec 06, 2025 · Louis Nervegna ♥ 10 · 💬 2

Louis shares a Luigi Fontana summary of a JAMA Oncology analysis of 29,105 Nurses' Health Study II women under 50 followed for 24 years. Higher ultraprocessed food intake was associated with 45% higher odds of conventional early-onset adenomas, with no clear link to serrated lesions. Louis adds that the same Harvard group previously found most UPF-related CVD risk came from processed meat and sugary beverages.

Video: large cohorts show no link between seed oils and prostate or colon cancer

Dec 23, 2024 · Louis Nervegna ♥ 5 · 💬 5 Fats & oils (saturated fat, seed oils, omega-6, olive oil)

Louis shares a Nutrition Made Simple video analyzing two headline-making studies tying seed oils to cancer. Large prospective cohorts show no association with prostate cancer, and with colon cancer once ultra-processed food intake is corrected for. He adds that decades of research show no obvious relationship between fat intake and cancer.

Meta-analysis of 76 studies finds no link between wine drinking and cancer risk

Dec 03, 2023 · Louis Nervegna ♥ 3 · 💬 5 ↩ 3 Alcohol, smoking & vaping

Louis highlights a Frontiers in Nutrition systematic review and meta-analysis of 76 epidemiological studies, which found no association between wine consumption and any cancer and a protective trend for pancreatic, skin, lung, brain and overall cancer. He cautions that observational data cannot prove wine is harmless, and advises staying within guidelines of at most 2 drinks a day for men and 1 for women.

Processed meat forms nitrosamines in the stomach whatever the nitrite source

May 21, 2026 · Louis Nervegna ♥ 13 · 💬 1 Meat, eggs & dairy

Louis shares a Journal of Theoretical Biology paper: nitrite from curing (or celery juice) reacts in stomach acid to form nitrosamines such as NDMA and NDEA, a leading hypothesis for processed meat's link to stomach and colorectal cancer. Vitamin C might reduce their formation. WHO classes processed meat as a group 1 carcinogen.

CHIP (clonal hematopoiesis): a little-known risk factor for heart disease and stroke

Apr 08, 2024 · Gokhan Can ♥ 5 · 💬 3 Risk assessment & lab tests

Explains clonal hematopoiesis of indeterminate potential: blood cells carrying acquired mutations that raise the risk of blood cancers, coronary disease and stroke. It becomes more common with age, can be detected with a next-generation sequencing panel, and has no specific treatment yet. The post notes testosterone therapy and anything strongly stimulating bone marrow may help CHIP expand.

Swapping 10% of carb calories for vegetable fats cut lethal prostate cancer 29%

Dec 20, 2024 · Louis Nervegna ♥ 6 · 💬 2 Fats & oils (saturated fat, seed oils, omega-6, olive oil)

Louis quotes a UCSF-led study of nearly 4,600 men with non-metastatic prostate cancer. Substituting healthy vegetable fats (olive and canola oil, nuts, seeds, avocado) for carbohydrates or animal fats was associated with lower lethal prostate cancer and all-cause mortality. The study adjusted for age, treatment, BMI, smoking, exercise and other factors.

Harvard review: fat not clearly linked to cancer; red and processed meat raise colon risk

Dec 20, 2024 · Louis Nervegna ♥ 4 · 💬 2 ↩ 1 Fats & oils (saturated fat, seed oils, omega-6, olive oil)

Louis quotes the Harvard Nutrition Source summary on dietary fat and cancer. Total fat percentage and fat types show no clear association with cancer, and the Women's Health Initiative low-fat trial did not reduce breast or colon cancer. Red and processed meat do increase colon cancer risk, and animal fat in young women was linked to higher breast cancer risk in Nurses' Health Study II. He notes a later Harvard study updates this.

Paricalcitol plus chemo safe in 36 pancreatic cancer patients; reduced tumor fibroblasts

Jun 05, 2026 · Louis Nervegna ♥ 8 · 💬 2

Louis points to a Nature Cancer study from Dana-Farber in which the vitamin D analog paricalcitol was combined with chemotherapy in 36 patients with untreated metastatic pancreatic cancer. Biopsies showed reduced fibroblast activation and more T-cell infiltration; the trial was not designed to prove survival benefit and it is not about vitamin D supplements.

Glucose plus fructose promotes colorectal cancer metastasis via SORD (Nature Metabolism)

Sep 22, 2025 · Louis Nervegna ♥ 5 · 💬 2

A Nature Metabolism study shows the glucose and fructose combination found in sugar-sweetened beverages promotes colorectal cancer metastasis through sorbitol dehydrogenase (SORD). Louis notes large prospective cohorts have repeatedly linked sugary drinks with colon cancer and that this may explain a mechanism.

Metformin gave 60% histological response in oral premalignant lesions (phase IIa)

Dec 28, 2024 · Louis Nervegna ♥ 5 · 💬 2 ↩ 2

Louis shares a single-arm phase IIa trial of metformin (up to 2,000 mg/day for 12 weeks) in non-diabetic people with oral premalignant lesions. Histological response was 60%, while clinical response (50% size reduction) was 17%, with reduced mTOR activity correlating with response.

Vitamin B3 forms and NAD: strong evidence in skin cancer, only preliminary in glioblastoma

Jun 25, 2026 · Louis Nervegna ♥ 12 ↩ 2

Louis notes randomized trials show nicotinamide can reduce certain skin cancers, and early niacin trials are testing glioblastoma, with both likely acting through NAD. The shared analysis stresses the brain-cancer result comes from 15 patients with no control group, while the skin-cancer effect is real but modest.

Low LDL's link to cancer is reverse causality: cancer lowers cholesterol, not vice versa

Dec 21, 2023 · Louis Nervegna ♥ 5 · 💬 1 LDL, ApoB & lipid panel

Louis explains why observational studies linking low LDL to cancer are not causal. Citing a Circulation review on reverse causality, he notes cholesterol declines before cancer diagnosis (likely from cancer-related inflammation), statin RCTs show no increase in cancer, and Mendelian randomization with an average of 52 years of lifetime exposure shows no higher cancer rates in people with genetically lower cholesterol.

Statin use linked to 35% lower odds of liver cancer in UK database study

Sep 15, 2026 · Louis Nervegna ♥ 10 Statins

A UK Clinical Practice Research Datalink case-control study of 3,719 liver cancer cases and 14,876 controls found statin users had 35% lower odds of liver cancer, and cholesterol absorption inhibitors (ezetimibe class) 31% lower odds. This is an association, not proof, and non-statin findings need replication.

Daraxonrasib for pancreatic cancer already offered at Mass General Brigham

Aug 18, 2026 · Louis Nervegna ♥ 9 · 💬 1

Louis reports that Mass General Brigham is treating pancreatic cancer patients with daraxonrasib through the FDA Expanded Access Program ahead of approval, and suggests other large hospitals may do the same. Coverage describes it as a historic pill that could double life expectancy in advanced disease.

Creatine and cancer metastasis: preclinical signal, but human evidence is reassuring

Sep 18, 2026 · Louis Nervegna ♥ 2 · 💬 3 Supplements & vitamins

A summary of the claim that creatine promotes cancer spread. Animal and cell models showed more metastasis and worse survival, but human data are much less alarming: higher dietary creatine was linked to lower cancer risk, and a trial giving creatine to cancer patients found no survival difference. The poster says people with cancer should discuss supplementation with their oncology team.

High-dose niacin shows early promise in glioblastoma: 82% progression-free at 6 months

Oct 12, 2026 · Louis Nervegna ♥ 6

A small phase 1 pilot trial of high-dose, controlled-release niacin added to standard chemotherapy and radiotherapy for glioblastoma reported 82% of patients progression-free at six months. The poster notes the doses resemble those once used for high cholesterol and that results used historical controls, so a randomized phase 2 trial is ongoing.

Small RCT: vitamin D raised pathological complete response to 43% vs 24% in breast cancer

Jul 25, 2026 · Louis Nervegna ♥ 3 Supplements & vitamins

In an 80-woman Brazilian trial, women aged 45+ starting neoadjuvant chemotherapy received 2,000 IU vitamin D daily or placebo for six months. Complete response occurred in 43% vs 24% among 75 who reached surgery. The commentary notes the benefit tracked correction of deficiency and that pathologic complete response is not a validated surrogate endpoint.

JACC review: guidelines favor whole-food plant-based diets for CVD and cancer prevention

Dec 08, 2025 · Louis Nervegna ♥ 3 Mediterranean, DASH, MIND & plant-forward diets

Louis quotes a September 2025 JACC: CardioOncology state-of-the-art review noting that AHA, ACC, ACS, NCCN and WCRF/AICR guidelines all recommend a predominantly whole-food plant-based diet, as does the EAT-Lancet consensus. Patterns like Mediterranean and DASH are included, emphasizing fruits, vegetables, whole grains, legumes, nuts, seeds and olive oil while minimizing red meat.

ERSPC 23-year follow-up: PSA screening cut prostate cancer deaths 13% with overdiagnosis

Nov 15, 2025 · Gokhan Can ♥ 4

Summarises the 23-year European Randomized Study of Screening for Prostate Cancer follow-up: 13% lower prostate cancer mortality (22 fewer deaths per 10,000 men), one death prevented per 456 men invited (628 at 16 years), with higher diagnosis rate (14% vs 12%) reflecting overdiagnosis. Authors call for risk-based screening.

Waist circumference beat BMI for predicting obesity-related cancer in 339,000 Swedish men

Apr 16, 2025 · Louis Nervegna ♥ 2 Weight, visceral & liver fat

Luigi Fontana's summary of a large Swedish cohort showing waist circumference was a stronger predictor of obesity-related cancer than BMI in men, with added value after adjusting for BMI; the link was weaker in women. He argues abdominal fat signals metabolic dysfunction and should prompt deeper evaluation. Primarily cancer, linked to visceral fat.

Obesity may explain rising cancer rates in adults under 50

Feb 28, 2026 · Louis Nervegna ♥ 3

Shared article says early-onset cancers (thyroid, breast, colorectal, kidney, endometrial, leukemia) are rising in over three-quarters of countries studied, with obesity-driven inflammation and hormonal changes as likely drivers.

Vitamin D3 2,000 IU raised complete response to chemotherapy in breast cancer: 43% vs 24%

Oct 31, 2026 · Louis Nervegna ♥ 1

In an RCT of 80 women aged 45 or older receiving neoadjuvant chemotherapy for breast cancer, 2,000 IU daily vitamin D3 for six months was compared with placebo. Among 75 who completed treatment and had surgery, pathological complete response was 43% with vitamin D versus 24% with placebo. Small trial in cancer, not heart disease.

Growth-hormone peptides raise IGF-1, linked to cancer and mortality risk at high levels

May 11, 2026 · Louis Nervegna ♥ 1 Hormones, women's & men's health

Joel Kahn's post, shared by Louis, warns that injecting growth-hormone-type peptides (ipamorelin, sermorelin, CJC-1295) can chronically elevate IGF-1. High IGF-1 is associated in observational data with breast and prostate cancer and with higher cancer, cardiovascular and all-cause mortality, and excess GH signaling in acromegaly causes cardiometabolic complications.

Sweetener evidence links: NutriNet-Santé cancer cohort, WHO review, beverage meta-analysis

Jun 13, 2025 · Louis Nervegna ♥ 0 Carbs, fiber, sugar & whole grains

A link-only post gathering three sources on non-sugar sweeteners: the NutriNet-Santé cohort associating aspartame and acesulfame-K with cancer risk, a WHO systematic review and meta-analysis, and a 2022 Diabetes Care meta-analysis finding no cardiometabolic harm when low/no-calorie drinks substitute for sugary ones. There is no commentary.